MARKET

PRTC

PRTC

Puretech Health
NASDAQ
19.10
-0.68
-3.44%
Closed 15:59 04/01 EDT
OPEN
19.18
PREV CLOSE
19.78
HIGH
19.61
LOW
19.10
VOLUME
14.74K
TURNOVER
--
52 WEEK HIGH
34.00
52 WEEK LOW
16.30
MARKET CAP
457.29M
P/E (TTM)
-6.3491
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRTC last week (0324-0328)?
Weekly Report · 1d ago
Weekly Report: what happened at PRTC last week (0317-0321)?
Weekly Report · 03/24 11:09
Weekly Report: what happened at PRTC last week (0310-0314)?
Weekly Report · 03/17 11:19
PureTech Founded Entity Seaport Therapeutics Appoints Robert J. Hombach to its Board of Directors as Audit Committee Chair
Barchart · 03/11 06:05
Weekly Report: what happened at PRTC last week (0303-0307)?
Weekly Report · 03/10 11:21
Weekly Report: what happened at PRTC last week (0224-0228)?
Weekly Report · 03/03 11:20
PureTech to Present at the Leerink Partners Global Healthcare Conference
Barchart · 02/25 06:27
Weekly Report: what happened at PRTC last week (0217-0221)?
Weekly Report · 02/24 11:19
More
About PRTC
More
PureTech Health plc is a clinical stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has resulted in the development of around 29 therapeutics and therapeutic candidates, including two that have received both United States Food and Drug Administration (FDA) clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. Its product candidates include LYT-100, LYT-200, SPT-300, SPT-310 and SPT-320. LYT-100 (deupirfenidone) is being developed internally by the Company for the treatment of idiopathic pulmonary fibrosis (IPF). LYT-200 is being developed for the treatment of hematological malignancies, such as acute myeloid leukemia and high-risk myelodysplastic syndromes, as well as locally advanced/metastatic solid tumors. SPT-300 is an oral prodrug of allopregnanolone, which is being advanced for the treatment of anxious depression.
Recently
Symbol
Price
%Change

Webull offers PureTech Health PLC (ADR) stock information, including NASDAQ: PRTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRTC stock methods without spending real money on the virtual paper trading platform.